<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kusakabe M</submitter><funding>Scientific Research C</funding><funding>Scientific Research B</funding><funding>Early-Career Scientists from the Japan Society for the Promotion of Science</funding><funding>NVIDIA Corporation provided support to Jason Lin in the form of hardware devices</funding><funding>Grant-in-Aids for Scientific Research on Innovative Areas</funding><funding>The SAPOIN strategic elevation of basic scientific research initiative from the Ministry of Economy, Trade and Industry of Japan</funding><pagination>e12247</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8496461</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>Despite the benefit of early cancer screening, Japan has one of the lowest cancer screening rates among developed countries, possibly due to there being a lack of "a good test" that can provide sufficient levels of test sensitivity and accuracy without a large price tag. As a number of essential and trace elements have been intimately connected to the oncogenesis of cancer, Metallobalance, a recent development in elemental analysis utilizing the technique of inductively coupled plasma mass spectrometry has been developed and tested as a robust method for arrayed cancer risk screening. We have conducted case-control epidemiological studies in the prefecture of Chiba, in the Greater Tokyo Area, and sought to determine both Metallobalance screening's effectiveness for predicting pan-cancer ou</pubmed_abstract><journal>PeerJ</journal><pubmed_title>Elemental analysis by Metallobalance provides a complementary support layer over existing blood biochemistry panel-based cancer risk assessment.</pubmed_title><pmcid>PMC8496461</pmcid><funding_grant_id>221S0001</funding_grant_id><funding_grant_id>JP17K15047</funding_grant_id><funding_grant_id>JP20H03540</funding_grant_id><funding_grant_id>21K15072</funding_grant_id><funding_grant_id>16H06277</funding_grant_id><funding_grant_id>JP20K10440</funding_grant_id><pubmed_authors>Nagase H</pubmed_authors><pubmed_authors>Kusakabe M</pubmed_authors><pubmed_authors>Nakamura Y</pubmed_authors><pubmed_authors>Sato M</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Mikami H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Elemental analysis by Metallobalance provides a complementary support layer over existing blood biochemistry panel-based cancer risk assessment.</name><description>Despite the benefit of early cancer screening, Japan has one of the lowest cancer screening rates among developed countries, possibly due to there being a lack of "a good test" that can provide sufficient levels of test sensitivity and accuracy without a large price tag. As a number of essential and trace elements have been intimately connected to the oncogenesis of cancer, Metallobalance, a recent development in elemental analysis utilizing the technique of inductively coupled plasma mass spectrometry has been developed and tested as a robust method for arrayed cancer risk screening. We have conducted case-control epidemiological studies in the prefecture of Chiba, in the Greater Tokyo Area, and sought to determine both Metallobalance screening's effectiveness for predicting pan-cancer ou</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-06-01T02:38:29.789Z</modification><creation>2025-06-01T02:38:29.789Z</creation></dates><accession>S-EPMC8496461</accession><cross_references><pubmed>34707935</pubmed><doi>10.7717/peerj.12247</doi></cross_references></HashMap>